SNYR Wutah pendapatan kuartal marang kuartal Synergy CHC Corporation

Simbol lan logo merek Synergy CHC Corp. (SNYR)

Synergy CHC Corp (SNYR) operates in an oversaturated beauty products segment, leveraging aggressive digital marketing to expand its customer base. The holding company consolidates promising dietary supplement and cosmetic brands while optimizing their distribution. The business model relies on the efficiency of direct sales and pharmacy chains. The quarterly revenue growth rate demonstrates current capital stability, where -32.40 expresses the metric's value today.

SNYR (Synergy CHC Corp) riwayat Tingkat wutah pendapatan sajrone kuartal saka 24.10.2024 nganti 03.10.2026

Rincian analitis perusahaan Synergy CHC Corp

Analisis dhasar perusahaan:Synergy CHC Corporation - SNYR
Produk sing diprodhuksi Synergy CHC Corp

This indicator measures the quarterly expansion rate of cash flow from sales, allowing for an assessment of business scaling speed between financial reports. By analyzing the quarterly revenue growth rate, an investor can promptly detect stagnating demand in the B2C segment or, conversely, confirm the effectiveness of Synergy CHS Corp (SNYR) expansion via marketplaces and aggressive digital marketing.

Perusahaan pesaing

HLN - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal kenvue.com|Verona Pharma (VRNA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Amneal Pharmaceuticals Inc AMRX|Wutah pendapatan triwulanan PRGO|Owah-owahan dodolan kuartal marang kuartal ALVO|Wutah pendapatan triwulanan LQDA (Liquidia Technologies)|Wutah pendapatan triwulanan Galapagos GLPG|ANI Pharmaceuticals Inc - Wutah pendapatan triwulanan|MNKD (MannKind Corp.) - Wutah dodolan kuartal marang kuartal|AMPH: Wutah pendapatan triwulanan|PCRX (Pacira BioSciences) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ARS Pharmaceuticals Inc|Wutah dodolan triwulanan Theravance Biopharma, Inc. (TBPH)|Wutah dodolan triwulanan AQST (Aquestive Pharma)|SCPH - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan TECX (Tectonic Therapeutic, Inc.)|TNXP - Wutah dodolan triwulanan|China SXT Pharmaceuticals, Inc. - Wutah pendapatan triwulanan|EPRX - Wutah pendapatan triwulanan|BHST: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ENTX (Entera Bio)|Wutah pendapatan kuartal marang kuartal MindWalk (HYFT)|Wutah pendapatan triwulanan ABVC BioPharma, Inc. (ABVC)|Wutah pendapatan kuartal marang kuartal Cumberland Corp CPIX|QNTM - Wutah dodolan triwulanan|FGEN - Wutah pendapatan kuartal marang kuartal|TELO - Wutah pendapatan triwulanan|Rani Therapeutics Inc (RANI) - Wutah pendapatan kuartal marang kuartal|RLYB - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Lexaria Bioscience|Pulmatrix Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ftzy.com.cn (PTHL)|Aptorum Group - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan LYRA (Lyra Therapeutics Inc.)|Tingkat wutah dodolan sajrone kuartal Impact BioMedical (IBO)|TNF Pharmaceuticals - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal cbdMD Inc.|PainReform Ltd. (PRFX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Altamira Therapeutics (CYTO)|Wutah pendapatan kuartal marang kuartal Lipella Pharmaceuticals, Inc.|OPTN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Pieris (PIRS)|Wutah pendapatan triwulanan Procaps Group Corp (PROC)|Wutah pendapatan triwulanan PTPI (petrospharma.com)|Tambahing pendapatan triwulanan QLI|ACELYRIN - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan TFFP (TFF Pharmaceuticals Inc.)